Higher Dementia Risk Linked To Regular Laxative Use: Study
The Washington Post:Regular Laxative Use Correlated With Higher Dementia Risk In U.K. Study
Regular laxative use may be correlated with dementia, according to research published in the journal Neurology in February. The study looked at a cohort of 502,229 British adults participating in UK Biobank, a long-term initiative that gathered extensive genetic and health information from 40- to 69-year-olds in England, Wales and Scotland between 2006 and 2010. The participants had no history of dementia. Researchers compared those who reported no regular laxative use with those who said they used laxatives most days of the week for the past four weeks in surveys. (Blakemore, 3/4)
On the cost of insulin
Stat:Eli Lilly Will Avoid Big Medicaid Rebates After It Cut Insulin Prices
Eli Lilly wouldve had to pay Medicaid about $150 for each vial of insulin used in the program if it hadnt dramatically cut the list prices for some of its older products this week. The company was about to run into a Medicaid penalty for hiking the price of its drugs faster than the rate of inflation. Now that it plans to lower the list price of the insulin Humalog 70%, it wont trigger that penalty. Lilly also is lowering the price of Lispro, a biosimilar of Humalog, to $25 a vial. (Wilkerson, 3/6)
KHN:Journalists Discuss Insulin Prices, Gun Violence, Distracted Driving, And More
Midwest KHN correspondent Bram Sable-Smith discussed the Eli Lilly news on insulin prices on PBS NewsHour and insulin prices on Slates What Next on March 1. ... KHN contributor Andy Miller discussed Georgias legislative wrap-up including Medicaid work requirements on Georgia Public Broadcastings Lawmakers on Feb. 28. He also discussed health care for foster children on WUGAs The Georgia Health Report on Feb. 3. (3/4)
In other pharmaceutical news
CBS News:FDA Warns Of False Negative Results For Food Allergies After Skin Test Recall
All skin tests doctors commonly use to check for food allergies can provide false negative results, the Food and Drug Administration has concluded meaning people with potentially life-threatening allergies could mistakenly be told they are not at risk. The tests will now be required to include a warning urging doctors to consider double-checking the test with more accurate approaches. (Tin, 3/3)
NPR:Genome Summit To Weigh Pros And Cons Of Gene-Editing
Hundreds of scientists, doctors, bioethicists, patients, and others started gathering in London Monday for the Third International Summit on Human Genome Editing. The summit this week will debate and possibly issue recommendations about the thorny issues raised by powerful new gene-editing technologies. (Stein, 3/6)
Monday, March 6, 2023 at 1:46 pm